Expression of FHL2 and cytokine messenger RNAs in human myocardium after cardiopulmonary bypass

International Journal of Cardiology

Volumn 86, Issue 2-3, 2002, Pages 265-272

  Wan, Song ^a   Yim, Anthony P C ^a   Wong, Chun Kwok ^a   Arifi, Ahmed A ^a   Yip, Johnson H Y ^a   Ng, Calvin S H ^a   Waye, Mary M Y ^a   Lam, Christopher W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiopulmonary bypass; Cytokines; FHL2; Inflammatory response; Messenger RNA; Myocardial injury

Indexed keywords

CREATINE KINASE MB; CYTOKINE; FOUR AND A HALF LIM ONLY PROTEIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MUSCLE PROTEIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SURGERY; CREATINE KINASE BLOOD LEVEL; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION REGULATION; HEART ATRIUM MUSCLE; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART VALVE SURGERY; HUMAN; HUMAN TISSUE; MALE; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; AGED; CARDIOPULMONARY BYPASS; CYTOKINES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART DISEASES; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOCARDIUM; PROSPECTIVE STUDIES; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0036888342     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00331-5     Document Type: Article

References (33)

1. Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 112:1997;676-692.
2. Gurevitch J., Frolkis I., Yuhas Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol. 30:1997;1554-1561.
3. Sawa Y., Ichikawa H., Kagisaki K., Ohata T., Matsuda H. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg. 116:1998;511-517.
4. Boyle E.M. Jr., Kovacich J.C., Hèbert C.A., et al. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 116:1998;114-121.
5. Meldrum D.R., Meng X., Dinarello C.A., et al. Human myocardial tissue TNFα expression following acute global ischemia in vivo. J Mol Cell Cardiol. 30:1998;1683-1689.
6. Kukielka G.L., Smith C.W., Manning A.M., Youker K.A., Michael L.H., Entman M.L. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation. 92:1995;1866-1875.
7. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811.
8. Oz M.C., Liao H., Naka Y., et al. Ischemia-induced interleukin-8 release after human heart transplantation: a potential role for endothelial cells. Circulation. 92:(Suppl II):1995;428-432.
9. Liebold A., Keyl C., Birnbaum D.E. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur J Cardiothorac Surg. 15:1999;340-345.
10. Dreyer W.J., Phillips S.C., Lindsey M.L., et al. Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 120:2000;256-263.
11. Burns S.A., Newburger J.W., Xiao M., Mayer J.E. Jr., Walsh A.Z., Neufeld E.J. Induction of interleukin-8 messenger RNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation. 92:(Suppl II):1995;315-321.
12. Chan K.K., Tsui S.K.W., Lee S.M.Y., et al. Molecular cloning and characterization of FHL-2, a novel LIM domain protein preferentially expressed in human heart. Gene. 210:1998;345-350.
13. Chan K.K., Tsui S.K., Ngai S.M., et al. Protein-protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47. J Cell Biochem. 76:2000;499-508.
14. Li H.Y., Kotaka M., Kostin S., et al. Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization. Cell Motil Cytoskeleton. 48:2001;11-23.
15. Muller J.M., Isele U., Metzger E., et al. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:2000;359-369.
16. Scholl F.A., McLoughlin P., Ehler E., de Giovanni C., Schäfer B.W. DRAL is a p53-responsive gene whose four and a half lim domain protein product induces apoptosis. J Cell Biol. 151:2000;495-506.
17. Wan S., LeClerc J.L., Vincent J.L. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg. 63:1997;269-276.
18. Wan S., Marchant A., DeSmet J.M., et al. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 111:1996;469-477.
19. Irwin M.W., Mak S., Mann D.L., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 99:1999;1492-1498.
20. Kapadia S., Lee J., Torre-Amione G., Birdsall H.H., Ma T.S., Mann D.L. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 96:1995;1042-1052.
21. Frangogiannis N.G., Lindsey M.L., Michael L.H., et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 98:1998;699-710.
22. Meldrum D.R., Cleveland J.C., Cain B.S., Meng X., Harken A.H. Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg. 65:1998;439-443.
23. Torre-Amione G., Stetson S.J., Youker K.A., et al. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation. 100:1999;1189-1193.
24. Valen G., Paulsson G., Bennet A.M., Hansson G.K., Vaage J. Gene expression of inflammatory mediators in different chambers of the human heart. Ann Thorac Surg. 70:2000;562-567.
25. Satoh M., Nakamura M., Tamura G., et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol. 29:1997;716-724.
26. Valen G., Paulsson G., Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg. 71:2001;226-232.
27. Wan S., Izzat M.B., Lee T.W., Wan I.Y.P., Tang N.L.S., Yim A.P.C. Avoiding cardiopulmonary bypass in multivessel-CABG reduces cytokine response and myocardial injury. Ann Thorac Surg. 68:1999;52-57.
28. Murakami M., Hibi M., Nakagawa N., et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 260:1993;1808-1810.
29. Chandrasekar B., Mitchell D.H., Colston J.T., Freeman G.L. Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation. 99:1999;427-433.
30. Gwechenberger M., Mendoza L.H., Youker K.A., et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation. 99:1999;546-551.
31. Kukielka G.L., Smith C.W., LaRosa G.J., et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 95:1995;89-103.
32. Wan S., LeClerc J.L., Antoine M., DeSmet J.M., Yim A.P.C., Vincent J.L. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study. Ann Thorac Surg. 68:1999;1230-1235.
33. Wan S, Yim APC. Tai Ji: The law of inflammatory response [Editorial]. J Thorac Cardiovasc Surg (in press).